DBD vs. AGYS
DBD (Diebold Nixdorf, Incorporated) and AGYS (Agilysys, Inc.) are both stocks. Both operate in the Software - Application industry within the Technology sector. Over the past year, DBD returned 36.30% vs -8.55% for AGYS. Their 0.25 correlation means their historical movements had little consistent relationship.
Performance
DBD vs. AGYS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DBD achieves a 8.40% return, which is significantly higher than AGYS's -11.51% return.
DBD
- 1D
- 3.27%
- 1M
- -11.51%
- 6M
- 6.64%
- YTD
- 8.40%
- 1Y
- 36.30%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 55.83%
AGYS
- 1D
- -2.31%
- 1M
- -5.10%
- 6M
- 21.22%
- YTD
- -11.51%
- 1Y
- -8.55%
- 3Y*
- 12.32%
- 5Y*
- 13.61%
- 10Y*
- 25.41%
- ALL TIME*
- 10.86%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
AGYS Agilysys, Inc. | $35.74M | $31.69M | $35.96M |
| $28.97M | $24.08M | $24.87M |
DBD vs. AGYS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
DBD Diebold Nixdorf, Incorporated | 8.40% | 57.74% | 48.67% | 46.21% |
AGYS Agilysys, Inc. | -11.51% | -9.77% | 55.28% | 18.53% |
Correlation
The correlation between DBD and AGYS is 0.20, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.20 |
Correlation (All Time) Calculated using the full available price history since Aug 15, 2023 | 0.25 |
Fundamentals
DBD:
$2.50B
AGYS:
$2.97B
DBD:
$3.07
AGYS:
$1.51
DBD:
23.96
AGYS:
69.67
DBD:
0.06
AGYS:
0.40
DBD:
0.69
AGYS:
9.05
DBD:
2.68
AGYS:
8.83
DBD:
$3.87B
AGYS:
$330.31M
DBD:
$1.01B
AGYS:
$205.86M
DBD:
$341.80M
AGYS:
$61.03M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DBD vs. AGYS — Risk / Return Rank
DBD
AGYS
DBD vs. AGYS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Diebold Nixdorf, Incorporated (DBD) and Agilysys, Inc. (AGYS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DBD | AGYS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.93 | ||
| Sortino ratioReturn per unit of downside risk | +1.05 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.02 | +0.16 |
| Calmar ratioReturn relative to maximum drawdown | 1.37 | -0.14 | +1.51 |
| Martin ratioReturn relative to average drawdown | 4.17 | -0.25 | +4.42 |
Loading charts...
Drawdowns
DBD vs. AGYS - Drawdown Comparison
The maximum DBD drawdown since its inception was -25.76%, smaller than the maximum AGYS drawdown of -90.96%. Use the drawdown chart below to compare losses from any high point for DBD and AGYS.
Loading charts...
Drawdown Indicators
| DBD | AGYS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -25.76% | -90.96% | +65.20% |
Max Drawdown (1Y)Largest decline over 1 year | -22.53% | -55.93% | +33.40% |
Max Drawdown (3Y)Largest decline over 3 years | — | -56.12% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -56.12% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -64.72% | — |
Current DrawdownCurrent decline from peak | -18.91% | -25.81% | +6.90% |
Average DrawdownAverage peak-to-trough decline | -6.57% | -33.33% | +26.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.39% | 31.80% | -24.41% |
Volatility
DBD vs. AGYS - Volatility Comparison
Diebold Nixdorf, Incorporated (DBD) has a higher volatility of 20.92% compared to Agilysys, Inc. (AGYS) at 16.93%. This indicates that DBD's price experiences larger fluctuations and is considered to be riskier than AGYS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DBD | AGYS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.92% | 16.93% | +3.99% |
Volatility (6M)Calculated over the trailing 6-month period | 31.63% | 37.56% | -5.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 39.48% | 54.59% | -15.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 41.24% | 48.97% | -7.73% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.24% | 46.62% | -5.38% |
Dividends
DBD vs. AGYS - Dividend Comparison
Neither DBD nor AGYS has paid dividends to shareholders.
Financials
DBD vs. AGYS - Financials Comparison
This section allows you to compare key financial metrics between Diebold Nixdorf, Incorporated and Agilysys, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DBD vs. AGYS - Profitability Comparison
DBD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Diebold Nixdorf, Incorporated reported a gross profit of 239.60M and revenue of 930.80M. Therefore, the gross margin over that period was 25.7%.
AGYS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Agilysys, Inc. reported a gross profit of 55.66M and revenue of 87.68M. Therefore, the gross margin over that period was 63.5%.
DBD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Diebold Nixdorf, Incorporated reported an operating income of 57.40M and revenue of 930.80M, resulting in an operating margin of 6.2%.
AGYS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Agilysys, Inc. reported an operating income of 9.74M and revenue of 87.68M, resulting in an operating margin of 11.1%.
DBD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Diebold Nixdorf, Incorporated reported a net income of 15.50M and revenue of 930.80M, resulting in a net margin of 1.7%.
AGYS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Agilysys, Inc. reported a net income of 8.99M and revenue of 87.68M, resulting in a net margin of 10.3%.
Frequently Asked Questions
DBD and AGYS have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DBD has higher volatility (20.92%) compared to AGYS (16.93%). In terms of maximum drawdown, DBD dropped -25.76% vs AGYS's -90.96%.
DBD currently has the higher Sharpe Ratio (0.78 vs -0.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DBD and AGYS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer